Evaluation of Functional Disability in Rheumatoid Arthritis Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University

About this trial

Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune inflammatory disease that mainly affects the joints and periarticular soft tissues. Accurate monitoring of disease activity is a cornerstone of the treat-to-target approach in Rheumatoid arthritis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

number and site of involved joints (range 0-5)

serological abnormality (range 0-3)

elevated acute-phase response (range 0-1)

symptom duration (two levels; range 0-1).

Disqualifiers

• Other rheumatologic or collagen diseases.

Age below 18 years and above 65 years.

Uncooperative patients.

Trial population

This study will include 100 established Rheumatoid arthritis (RA) patients according the 2010 ACR/EULAR classification criteria for RA, who will be recruited from Rheumatology and Rehabilitation department at Sohag university hospital, in addition to 50 controls will be matched for sex, age, and level of schooling

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

150 Participants
are grouped into 2 trial groups
Group A: rheumatoid arthritis established patients
Group B: control group of non rheumatoid patients

Trial outcomes

Primary outcomes

1

To evaluate the performance of Rheumatoid Arthritis Impact of Disease (RAID) questionnaire in detecting disease flares in Rheumatoid arthritis patients and to compare it with other disease activity indices.

Time frame
1 year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: